功能性影像在脑胶质瘤放射治疗靶区确定中的应用

黄劲雄; 吴华

黄劲雄 , 吴华

文章导航 > 国际放射医学核医学杂志 > 2007, 31 > 2: (108-112)

引用本文:

Citation:

功能性影像在脑胶质瘤放射治疗靶区确定中的应用

黄劲雄,
吴华

361003 厦门, 福建医科大学附属厦门第一医院核医学科
中图分类号: R445.2;R817.4

The functional imaging in target volume delineation of radiotherapy planning for gliomas

Department ofNuclearMedicine, Xiamen First Hospital, Fujian Medical University, Xiamen 361003, China
CLC number: R445.2;R817.4

摘要: 放射治疗是脑胶质瘤的重要治疗手段之一。功能性影像如PET、SPECT、MRI等不仅有助于更准确地显示胶质瘤的浸润范围,还可揭示肿瘤病灶的血供、代谢、乏氧、增殖状态,从而为制定个体化的精确放疗计划提供更有价值的信息。
- 放射治疗计划,计算机辅助 /
- 磁共振成像 /
- 体层摄影术,发射型计算机 /
- 脑胶质瘤
Abstract: Radiotherapy is one of important treatments for glioma. Functional imaging, such as PET, SPECT and MRI, may provide more valuable information not only in display of the evasion extent of glioma but also in demonstration of some biological characteristics of the tumor, such as perfusion, metabolism, hypoxia or proliferation. Thus it may play a role in making an individualized and more exact radiotherapy planning.
- Radiotheraphy planning, computer-assisted /
- Magnetic resonance imaging /
- Tomograpy, emission-computed /
- Glioma
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Wetzel SG, Cha S, Law M, et al. Preoperative assessment of intracranial tumors with perfusion MR and a volumetric interpolated examination:a comparative study with DSA. Am J Neuroradiol,2002,23(10):1767-1774.
[2]	Lev MH, Hochberg F. Perfusion magnetic resonance imaging to assess brain tumor responses to new therapies. Cancer Control J,1998, 5(2):115-123.
[3]	Benard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med, 2003, 33(2):148-162.
[4]	Kracht LW, Miletic H, Busch S, et al. Delineation of brain tumor extent with[¹¹C] L-methionine positron emission tomography:local comparison with stereotactic histopathology. Clin Cancer Res, 2004,10(21):7163-7170.
[5]	Grosu A L, Weber W, Feldmann H J, et al. First experience with I-123-alpha-methyl-tyrosine speet in the 3-D radiation treatment planning of brain gliomas. Int J Radiat Oncol Biol Phys, 2000, 47(2):517-526.
[6]	Padma MV, Said S, Jacobs M, et al. Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol, 2003, 64(3):227-237.
[7]	Yokogami K, Kawano H, Moriyama T, et al. Application of SPECT using ^99mTcO₄-MIBI in brain tumors and comparison with expression of the MDR-lgene:is it possible to predict the response to chemotherapy in patients with gliomas by means of ^99mTcO₄-MIBI SPECT?. Eur J Nucl Med, 1998, 25(2):401-409.
[8]	Giammarile F, Houzard C, Bournaud C, et al. High and low grade oligodendrogliomas (ODG):correlation of amino-acid and glucose uptakes using PET and histological classifications. J Neurooncol,2004, 68(3):263-274.
[9]	Al-Hallaq HA, Zamora M, Fish BL, et al. MRI measurements correctly predict the relative effects of tumor oxygenating agents on hypoxic fraction in rodent BA1112 tumors. Int J Radiat Oncol Biol Phys, 2000, 47(3):481-488.
[10]	Alber M, Paulsen F, Eschmann SM, et al. On biologically conformal boost dose optimization. Phys Meal Biol, 2003, 48(2):31-35.
[11]	Chao KSC, Bosch WR, Mutic S, et al. A novel approach to overcome hypoxic tumor resistance:Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys, 2001, 49(4):1171-1182.
[12]	Chen W, Cloughesy T, Kamdar N, et al. Imaging proliferation in brain tumors with ¹⁸F-FLT PET:comparison with ¹⁸F-FDG. J Nucl Med, 2005, 46(6):945-952.
[13]	Fuss M, Wenz F, Essig M, et al. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys, 2001, 51(2):478-482,
[14]	Haubner R, Wester HJ, Weber WA, et al. Non-invasive imaging of αvβ3 integrin expression using a ¹⁸F-labeled RGD-containing glycopoptide and positron emission tomography. Cancer Res, 2001,61(5):1781-1785.

[1]	盛晓芳 , 管一晖 , 赵军 , 左传涛 . PET-CT在脑胶质瘤放射治疗靶区确定中的应用. 国际放射医学核医学杂志, 2005, 29(6): 241-244.
[2]	李峰生 , 陈肖华 . RNA干涉治疗脑胶质瘤的研究进展. 国际放射医学核医学杂志, 2007, 31(5): 300-302.
[3]	王洗 , 刘强 . 替莫唑胺联合适形放疗治疗恶性脑胶质瘤的临床观察. 国际放射医学核医学杂志, 2009, 33(2): 128-128. doi: 10.3760/cma.j.issn.1673-4114.2009.02.020
[4]	刘滔 , 严惟力 , 黄钢 . PET及PET-CT在放射治疗计划中的应用价值. 国际放射医学核医学杂志, 2007, 31(5): 281-284.
[5]	乔文礼 , 赵晋华 . ¹⁸F-氟脱氧葡萄糖PET在靶区确定和放疗计划制定中的价值. 国际放射医学核医学杂志, 2007, 31(6): 345-349.
[6]	郭慧敏 , 赵晋华 . 应用影像学方法评价乳腺癌新辅助化疗疗效. 国际放射医学核医学杂志, 2009, 33(3): 149-153. doi: 10.3760/cma.j.issn.1673-4114.2009.03.006
[7]	隗功华 , 孙晓光 . 医学影像学在肿瘤治疗疗效评价中的应用. 国际放射医学核医学杂志, 2009, 33(1): 43-46. doi: 10.3760/cma.j.issn.1673-4114.2009.01.043
[8]	朱苏雨 , 胡炳强 . PET-CT用于肿瘤精确放疗靶区勾画的困惑. 国际放射医学核医学杂志, 2007, 31(4): 217-221.
[9]	王静 , 姚振威 . 细胞磁共振成像技术在体示踪免疫细胞的研究进展. 国际放射医学核医学杂志, 2014, 38(5): 337-340. doi: 10.3760/cma.j.issn.1673-4114.2014.05.014
[10]	马彦云 , 张辉 . 磁共振体素内不相干运动扩散加权成像的原理及应用进展. 国际放射医学核医学杂志, 2016, 40(6): 469-473. doi: 10.3760/cma.j.issn.1673-4114.2016.06.013